List of Figures
Figure 1-1: Categorization & Function of Cancer Vaccines
Figure 2-1: Classification of Different Types of Cancer vaccines
Figure 4-1: Global Cancer Vaccines Market (US$ Billion), 2014-2020
Figure 4-2: Global Cancer Vaccines Market by Region (%), 2014 & 2020
Figure 4-3: Examples of Commercially Available Cancer Vaccines
Figure 4-4: Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-5: Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-6: Bladder Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-7: Bladder Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-8: Blood Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-9: Blood Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-10: Brain Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-11: Brain Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-12: Breast Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-13: Breast Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-14: Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-15: Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-16: Cervical Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-17: Cervical Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-18: Colorecta Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-19: Colorecta Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-20: Head & Neck Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-21: Head & Neck Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-22: Liver Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-23: Liver Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-24: Lung Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-25: Lung Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-26: Ovarian Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-27: Ovarian Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-28: Pancreatic Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-29: Pancreatic Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-30: Prostate Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-31: Prostate Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-32: Renal Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-33: Renal Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-34: Skin Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-35: Skin Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-36: Solid Tumour Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-37: Solid Tumour Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-38: Multiple Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-39: Multiple Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-40: No Development Reported Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-41: No Development Reported Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-42: Discontinued Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-43: Discontinued Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 4-44: Suspended Cancer Vaccine Drug Pipeline by Phase (%), 2015
Figure 4-45: Suspended Cancer Vaccine Drug Pipeline by Phase (Number), 2015
Figure 5-1: Overview of Personalized Cancer Vaccines Development
Figure 5-2: Methodology for the Development of Personalized Cancer Vaccine
Figure 5-3: Schematic Representation of Development of Skin Implant for Cancer Vaccine
Figure 6-1: Prophylactic Cancer Vaccines Available for Different Serotypes of HPV
Figure 7-1: Factors Responsible for High Demand of Cancer Vaccines
Figure 31-1: Advaxis Clinical Pipeline
Figure 31-2: Celldex Therapeutics Clinical Pipeline
Figure 31-3: Galena Biopharma Clinical Pipeline
Figure 31-4: ImmunoCellular Therapeutics Clinical Pipeline
Figure 31-5: ImmunoGen Clinical Pipeline
Figure 31-6: Inovio Pharmaceuticals Clinical Pipeline
Figure 31-7: KAEL-Gemvax Clinical Pipeline
Figure 31-8: NewLink Genetics Corporation Clinical Pipeline
Figure 31-9: Northwest Biotherapeutics Clinical Pipeline
Figure 31-10: Peregrine Pharmaceuticals Clinical Pipeline
Figure 31-11: Seattle Genetics Clinical Pipeline

 

List of Tables
Table 5-1: Different Types of Biomarkers For Personalized Cancer Vaccine Development